Abstract

BackgroundBladder tumors in pregnancy are extremely rare. No more than 50 cases have been published to date, including all histologic variants, and only three cases of bladder squamous cell carcinoma have been described.Case presentationWe present a clinical case of a 31-year-old woman with bladder squamous cell carcinoma in the second trimester of pregnancy. After a C-section at 30 weeks, we performed radical cystectomy with extended bilateral lymphadenectomy, hysterectomy and right oophorectomy. The Studer neobladder technique was performed for urinary tract reconstruction. Definitive pathology showed invasive bladder squamous cell carcinoma, Grade 2, with microscopic infiltration of the perivesical fat, negative margins, and 3/28 lymph nodes with carcinoma (pT3aN2M0). The patient underwent 18 months of surveillance after radical cystectomy, without recurrence by PET-CT.ConclusionsBladder cancer in pregnant women is extremely rare but must be considered in those with recurrent gross hematuria and/or recurrent urinary tract infection. To our knowledge, this case involves the longest recurrence-free survival of a pregnant woman with squamous cell bladder cancer published thus far.

Highlights

  • Bladder tumors in pregnancy are extremely rare

  • Case presentation We present the case of a healthy 31-year-old woman with an obstetric history of 1 pregnancy, 1 live birth, no abortions (G1P1A0), and a urinary tract infection in the first and second trimesters, without complications

  • Risk factors for squamous cell bladder tumors are a history of catheter use, smoking and recurrent urinary tract infections [8]

Read more

Summary

Conclusions

Bladder cancer in pregnant women is extremely rare but must be considered in those with recurrent gross hematuria and/or recurrent urinary tract infection. This case involves the longest recurrencefree survival of a pregnant woman with squamous cell bladder cancer published far

Background
Findings
Discussion and conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call